PINE Pharmaceuticals will be introducing the next generation of our combination drops at the upcoming VRS Foundation Retinal Update 2017 to be held February 3rd & 4th at The Westin – Galleria in Edina, Minnesota.
During the symposium our team will be presenting TPC Drops, an ophthalmic compound consisting of:
Tropicamide 1% – Phenylephrine HCl 2.5% – Cyclopentolate HCl 1%.
TPC Drops are designed to serve as a cost saving, single drop solution. Thus, helping clinicians save time and dilate the same number of patients for a fraction of the cost compared to using separate drops. Development of TPC Drops began last year after the tremendously successful launch of their predecessor, TROPIcamide-PHENylephrine.
Representatives will be available at our booth to discuss all PINE Pharmaceuticals products or simply contact us for information at: Orders@PinePharmaceuticals.com or by calling: 844-218-4138